Administration of aspirin and risk of pancreatic ductal adenocarcinoma

Administration of aspirin and risk of pancreatic ductal adenocarcinoma

A recent study by Sanat et al. (2023) investigated Aspirin’s potential protective effects against Pancreatic Ductal Adenocarcinoma (PDAC), leveraging its antioxidant and anti-inflammatory properties1. This case-control study included 470 PDAC patients and 526 matched controls from Shariati Hospital...

Full description

Saved in:
Bibliographic Details
Main Authors: Arooba Noor Abbasi, Fatimah Bismah Athar, Arooba Lakho
Format: Article
Language:English
Published: Pakistan Medical Association 2024-12-01
Series:Journal of the Pakistan Medical Association
Subjects:
Aspirin
Low-dose aspirin,
Pancreatic Cancer
Pancreatic duct
Online Access:https://jpma.org.pk/index.php/public_html/article/view/20483
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items